Tag: healthbiz

Interview with Hint Health CEO Zak Holdsworth

November 18th, 2021 by

Zak headshot 20191
Hint Health CEO Zak Holdsworth

Zak Holdsworth came all the way from a New Zealand farm to help reform the US healthcare system. At Hint Health he’s enabling a direct care model that frees (mostly) primary care practices from the overheads, hassles and misaligned incentives of third-party reimbursement. In his view, health insurance should pay for the occasional, unpredictable and expensive occurrences, not be the default payment method for predictable care.

Hint handles about a half billion dollars of payments now and is developing new tools to enable innovative approaches by health plans and employers.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with Congruity CEO Justin Davis

October 28th, 2021 by

Justin Davis headshot
Congruity Health CEO Justin Davis

Congruity Health CEO Justin Davis started his career as a math teacher and football coach before moving into healthcare –where he still uses math and football strategy!

In this episode of the HealthBiz podcast, Justin shares how Congruity leverages technology to help telemedicine companies identify the right interventions at the right time for the right patients with cardiometabolic conditions. With backing from its lead investor and strategic partner, Aviv Growth, Congruity is now moving into the realm of musculoskeletal disorders as well.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with Better Health CEO Naama Stauber Breckler

October 21st, 2021 by

better health Naama headshot1
Better Health CEO Naama Stauber Breckler

Naama Stauber Breckler grew up on a moshav, an environment that encouraged a lot of exploration. She was an officer and software engineer in the Israel Defense Forces, then worked for defense and security companies before moving to the US a decade ago.

At Stanford Business School, she found her calling in healthcare through cross-functional collaboration on unsolved problems, starting with catheters. She learned through her startup experience about deficiencies in distribution and patient support and decided there had to be a better way.

And now, she’s created Better Health, a startup that takes urology and ostomy supply to the next level with simple processes, personal consultations with experts, peer coaching and education. It’s the kind of experience I would want for myself and loved ones. 

In this episode of the HealthBiz podcast, Naama explains what’s better about Better Health, and how the company is striving to bring value based care to a corner of the market where it hasn’t really been seen. Better Health is ramping up, having just announced a Series A financing led by Caffeinated Capital and General Catalyst.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

Interview with Aristea Therapeutics CEO James Mackay

October 7th, 2021 by

James MacKay grew up in Scotland, and was encouraged by his father to pursue a career in business –but not the family business. Instead he earned a PhD in genetics and began a long stint with AstraZeneca, eventually jumping across the pond and all the way to San Diego. He continued with A companies like Ardea an now Arthrosi and Aristea, where he’s even done a deal with Arena.

In this episode of the HealthBiz podcast James talks about how he and his team at Aristea Therapeutics are applying their decades of experience to develop a drug they licensed from AstraZeneca. The first indication is PPP –no not purchasing power parity or the paycheck protection program– but palmoplantar pustulosis, a nasty illness with no good treatments today. We talk about why good drugs get left on the shelf at big pharma, and the future of the biotech industry and San Diego.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.

 

Interview with epocrates General Manager Diane Bartoli

September 2nd, 2021 by

Diane Bartoli Headshot
epocrates GM Diane Bartoli

Epocrates General Manager Diane Bartoli’s background is a little different from most of my guests. She majored in English and most of her career has been in publishing, with stints at Random House, Elsevier and Amazon’s Kindle before joining athenahealth to lead its epocrates business.

I’ve followed epocrates for decades –since they started out as mobile app on the Palm Pilot. When athenahealth acquired them about 8 years ago I interviewed the executive who did the deal. He talked about basking in epocrates’ ‘love halo’ and some other interesting rationales.

Diane has been hard at work steering epocrates through the pandemic. Demand is up for reliable information for clinicians about covid in particular, and so business is good. Unsurprisingly, Diane has a few book recommendations, including The Winter Fortress, written by her husband Neal Bascomb. And Diane is quick to point out that she mainly reads on the Kindle.

The HealthBiz podcast is available on SpotifyApple PodcastsGoogle PodcastsYouTube and  many more services. Please consider rating the podcast on Apple Podcasts.


By healthcare business consultant David E. Williams, president of Health Business Group.